Acorn Capital Advisors »

Aura Biosciences shares owned by Acorn Capital Advisors

Quarter-by-quarter ownership of Aura Biosciences (AURA) shares owned by Acorn Capital Advisors from 13F filings

Historical chart of Acorn Capital Advisors investment in Aura Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aura Biosciences held by Acorn Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aura Biosciences by Acorn Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-03-31 $1.5M 591k 2.46

More positions owned by Acorn Capital Advisors

Cg Oncology (CGON)
Urogen Pharma (URGN)
Y Mabs Therapeutics (YMAB)
Trevi Therapeutics (TRVI)
Candel Therapeutics (CADL)
Puma Biotechnology (PBYI)
Bicara Therapeutics (BCAX)
Protara Therapeutics Com Stk (TARA)
Terns Pharmaceuticals (TERN)
Onkure Therapeutics Class A Com (OKUR)
Verastem (VSTM)
Cybin Com New (CYBN)
Cardiff Oncology (CRDF)
Optinose Com New
Aadi Bioscience (WHWK)

View all positions for Acorn Capital Advisors

Top funds holding Aura Biosciences

Matrix Capital Management Company
Adage Capital Partners GP
BlackRock
Long Focus Capital Management
Medicxi Ventures Management
Suvretta Capital Management
Franklin Resources
Vanguard Group
Levin Capital Strategies
Nantahala Capital Management
Geode Capital Management
State Street Corporation
UBS Group
Regency Capital Management
Acorn Capital Advisors

View all funds holding Aura Biosciences